I will admit today this stock is not good for investors. The only winner is the shorters. With heavy heart congratulation guys. I feel so sorry for all the long-term holders including me. Very disappointing to see this kind of rate and trading today.
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Update on COVID-19 ARDS Trial
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-119
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.18 |
Change
0.013(1.07%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.15 | $1.20 | $1.15 | $1.344M | 1.148M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 2929 | $1.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 61849 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 2121 | 1.175 |
17 | 124835 | 1.170 |
12 | 120177 | 1.165 |
14 | 170586 | 1.160 |
10 | 470765 | 1.155 |
Price($) | Vol. | No. |
---|---|---|
1.180 | 62054 | 9 |
1.185 | 49927 | 9 |
1.190 | 145600 | 13 |
1.195 | 104633 | 12 |
1.200 | 93817 | 15 |
Last trade - 11.11am 16/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online